ARDX
Ardelyx Inc
NASDAQ: ARDX · HEALTHCARE · BIOTECHNOLOGY
$6.01
+0.67% today
Updated 2026-04-29
Market cap
$1.47B
P/E ratio
—
P/S ratio
3.62x
EPS (TTM)
$-0.26
Dividend yield
—
52W range
$3 – $8
Volume
3.6M
Ardelyx Inc (ARDX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.41M | $28.93M | $31.62M | $24.03M | $24.03M | $42.00M | $2.61M | $5.28M | $7.57M | $10.10M | $52.16M | $124.46M | $333.62M | $407.32M |
| Revenue growth (YoY) | — | +434.7% | +9.3% | -24.0% | +0.0% | +74.8% | -93.8% | +102.6% | +43.4% | +33.4% | +416.6% | +138.6% | +168.1% | +22.1% |
| Cost of revenue | $1.91M | $28.09M | $32.88M | $1.33M | $1.29M | $8.40M | $466000.00 | $600000.00 | $145000.00 | $1.00M | $4.12M | $17.80M | $50.56M | $39.54M |
| Gross profit | $3.50M | $835000.00 | $31.62M | $24.03M | $22.73M | $33.60M | $2.14M | $4.68M | $7.43M | $9.10M | $48.04M | $106.66M | $283.06M | $367.78M |
| Gross margin | 64.7% | 2.9% | 100.0% | 100.0% | 94.6% | 80.0% | 82.1% | 88.6% | 98.1% | 90.1% | 92.1% | 85.7% | 84.8% | 90.3% |
| R&D | $10.18M | $28.09M | $25.90M | $39.88M | $94.16M | $75.48M | $69.37M | $71.68M | $65.05M | $91.14M | $35.20M | $35.54M | $52.32M | $71.53M |
| SG&A | $4.03M | $3.70M | $7.29M | $13.53M | $18.73M | $23.23M | $23.71M | $24.27M | $33.15M | $72.30M | $76.60M | $134.40M | $258.69M | $337.23M |
| Operating income | $-8.80M | $-2.87M | $-1.56M | $-29.39M | $-112.89M | $-65.11M | $-90.95M | $-91.26M | $-90.78M | $-154.35M | $-63.76M | $-63.28M | $-27.95M | $-40.98M |
| Operating margin | -162.8% | -9.9% | -4.9% | -122.3% | -469.9% | -155.0% | -3488.6% | -1728.1% | -1199.0% | -1528.6% | -122.2% | -50.8% | -8.4% | -10.1% |
| EBITDA | $-8.13M | $-2.27M | $-1.26M | $-28.56M | $-111.60M | $-62.48M | $-85.08M | $-84.57M | $-85.24M | $-150.85M | $-60.98M | $-55.35M | $-16.71M | $-29.17M |
| EBITDA margin | -150.3% | -7.9% | -4.0% | -118.9% | -464.5% | -148.8% | -3263.6% | -1601.4% | -1125.9% | -1494.0% | -116.9% | -44.5% | -5.0% | -7.2% |
| EBIT | $-8.80M | $-2.87M | $-1.56M | $-29.39M | $-112.89M | $-65.11M | $-87.76M | $-88.91M | $-89.21M | $-153.66M | $-62.13M | $-56.65M | $-18.78M | $-32.23M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.53M | $5.73M | $5.10M | $4.50M | $5.07M | $8.87M | $20.09M | $28.40M |
| Income tax | $950000.00 | $141000.00 | $67000.00 | $-29000.00 | $29000.00 | $1.18M | $4000.00 | $303000.00 | $2000.00 | $4000.00 | $8000.00 | $547000.00 | $266000.00 | — |
| Effective tax rate | -10.8% | -2.2% | -2.1% | 0.1% | -0.0% | -1.9% | -0.0% | -0.3% | -0.0% | -0.0% | -0.0% | -0.8% | -0.7% | 0.0% |
| Net income | $-9.79M | $-6.56M | $-3.21M | $-29.62M | $-112.39M | $-64.34M | $-91.30M | $-94.94M | $-94.31M | $-158.16M | $-67.21M | $-66.07M | $-39.14M | $-61.60M |
| Net income growth (YoY) | — | +32.9% | +51.0% | -821.6% | -279.4% | +42.8% | -41.9% | -4.0% | +0.7% | -67.7% | +57.5% | +1.7% | +40.8% | -57.4% |
| Profit margin | -180.9% | -22.7% | -10.2% | -123.3% | -467.8% | -153.2% | -3502.0% | -1797.8% | -1245.7% | -1566.5% | -128.9% | -53.1% | -11.7% | -15.1% |